HALO Latest Headlines

Halozyme Therapeutics Non-GAAP EPS of $2.39 beats by $0.03, revenue of $493M beats by $1.44M

at seekingalpha.com (Thu, 5-Nov 4:08 PM)

Halozyme (HALO) Receives a Buy from H.C. Wainwright

at www.tipranks.com (Tue, 3-Nov 4:30 AM)

Halozyme expands argenx pact to eight ENHANZE targets, reinforcing the platform’s reach in subcutaneous delivery

Market Chameleon (Wed, 7-Oct 11:45 AM)

Halozyme plans $1.05B convertible notes due 2033, pairing the deal with capped calls and potential buybacks of its 2027 and 2028 converts

Market Chameleon (Thu, 17-Sep 9:30 AM)

HALO Raises the Bar: Record Results, Expanded Guidance, and Major Collaborations Define a Standout Quarter

Market Chameleon (Fri, 7-Aug 10:39 AM)